Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof
Patent
1995-06-07
2000-05-02
Scheiner, Laurie
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Virus or component thereof
4241881, 530350, A61K 3921
Patent
active
060569638
ABSTRACT:
This invention is directed to a composition comprising one or more human immunodeficiency virus type 2 (HIV-2) envelope proteins and a pharmaceutically acceptable carrier. The proteins of the claimed invention are gp300, p200 and p90/80 of HIV-2. The composition is useful for the diagnostic assay of HIV-2 and as an antigen for the production of antibodies, for example.
REFERENCES:
patent: 4839288 (1989-06-01), Montagnier et al.
Veronese, "Indentification of Simian Immunodeficiency Virus SIV MAC env Gene Products", Journal of Virology, 1416-1419, 1989.
Graham et al., 1995, New Engl. J. Med. 333:1331-1339.
Haynes, B., 1993, Science 260:1279-1286.
Cuille Marie-Anne Rey
Hovanessian Ara G.
Krust Bernard
Laurent-Crawford Anne G.
Montagnier Luc
Institut Pasteur and Centre Nationale de la Recherche Scientifiq
Parkin Jeffrey S.
Scheiner Laurie
LandOfFree
Immunogenic compositions comprising glycosylated and deglycosyla does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunogenic compositions comprising glycosylated and deglycosyla, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunogenic compositions comprising glycosylated and deglycosyla will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1592009